Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Scientific References Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial
Is AOD 9604 the Right Fit for You
Considering the market demand, evolving medical researchers have dedicated their time to developing effective anti-obesity medications and making your weight loss journey slightly achievable
Source: PubChem Sequence : YLRIVQCRSVEGSCGF Length : 16 amino acids Disulfide Bridge : Cys7Cys15 Formula : CHNOS Monoisotopic Mass : ~1,813.86 Da (native), ~1,929.92 Da (alkylated) IUPAC Name : Detailed stereochemical descriptor SMILES : Linear chemical chain encoding AOD9604 is studied in experimental models as a tool compound for investigating metabolic signaling and adipose tissue biology
Most common is injection site irritation (redness, swelling, or itching)
